Researchers at Pohang University of Science and Technology (POSTECH) have built a platform that steers cell behavior using ...

Expanding nucleic acid delivery business with new applications Ongoing optimization of cost structure Advancing plans for spin-off of nucleic acid delivery business and continuing strategic ...

Expanding nucleic acid delivery business with new applicationsOngoing optimization of cost structureAdvancing plans for spin-off of nucleic acid delivery business and continuing strategic repositionin ...

Genovis AB today announces the commercial launch of SEQguard Dino Preserve, an RNA preservation product tested and optimized for Plasmidsaurus, a leading Sequencing as a Service company. The product e ...

Researchers have found that certain bacteria carry a naturally occurring system, built from repurposed CRISPR components, ...

"If it ain't broke, don't fix it," goes the old adage, which Rice University professor James Chappell completely ignored in a ...

We have some tools to control bacteria, like antibiotics, but antibiotic resistance is a growing problem that is a threat to public health. Bacterial cells can easily cooperate, which can really help ...

[L-R] Baisong Mei, Anna O'Driscoll chat with City Therapeutics CEO Andy Orth. City Therapeutics, a startup whose co-founders include RNA interference drug pioneer John Maraganore, PhD, is building a ...

Defects in Calreticulin (Calr) and ER protein 57 (ERp57), two tandem endoplasmic reticulum (ER) resident proteins, are associated with pathologies ranging from protein conformational disorders to ...

According to the RNA world hypothesis, life began when RNA molecules evolved the ability to make more copies of themselves. Now we have discovered an RNA molecule that is almost capable of this – it ...

Roche is continuing its return to the RNA space by paying $200 million for the worldwide license to one of SanegeneBio’s programs. The companies didn’t specify which indication the program is focused ...